scholarly journals Tratamento cirúrgico de fibroma ossificante juvenil psamomatoide: relato de caso clínico

2020 ◽  
Vol 9 (2) ◽  
Author(s):  
Leticia Thais Otaviano ◽  
Cristian Statkievicz ◽  
Christopher Henrique Gibim ◽  
Denise da Rosa Furtado ◽  
Ricardo Alves Matheus ◽  
...  
Keyword(s):  
Case Report ◽  
Bone Cyst ◽  
World Health ◽  
Ossifying Fibroma ◽  
Management Options ◽  
Diagnosis And Management ◽  
Juvenile Ossifying Fibroma ◽  
Psammomatoid Ossifying Fibroma ◽  
Belo Horizonte ◽  
Health Organization

Introdução: O fibroma ossificante juvenil psamomatoide é um neoplasma de tecido conjuntivo fibroso celularizado, tipicamente não encapsulados de limites bem definidos, de crescimento rápido e assintomático, acometendo principalmente maxila de pacientes jovens. O diagnóstico geralmente acontece pela observação clínica da expansão cortical e deformidade facial evidente. Radiograficamente apresentam-se como lesões radiolúcidas circunscritas, com possíveis áreas radiopacas centrais. O tratamento cirúrgico através da excisão cirúrgica e curetagem parece ser o mais adequado em vista da agressividade expansiva da lesão e da baixa taxa de recidiva. Objetivo: O objetivo desse trabalho é relatar o tratamento cirúrgico de um paciente do gênero masculino, jovem, diagnosticado com fibroma ossificante juvenil psamomatoide de grande dimensões em seio maxilar esquerdo. Caso clínico: Clinicamente assintomático, com expansão da cortical óssea em fundo de sulco maxilar esquerdo, divergência de raízes dentárias, estreitamento da fossa nasal e deformidade facial esquerda, o exame radiográfico panorâmico evidenciava lesão radiolúcida circunscrita com áreas radiopacas. O tratamento de escolha foi a excisão cirúrgica completa da lesão através do acesso único de Weber-Ferguson para prover adequado acesso a todas as regiões envolvidas e manutenção da morfologia da face por meio de reconstrução com malha de titânio. Este relato de caso ilustra a conduta frente a fibroma ossificante juvenil psamomatoíde de grande proporção. Conclusão: Apesar do acesso cirúrgico eleito, a estética facial foi pouco comprometida, a malha de titânio proveu manutenção apreciável do tecido mole e a área operada encontra-se em acompanhamento pós-operatório para eventual futura reconstrução.Descritores: Fibroma Ossificante; Neoplasias de tecido ósseo; Cirurgia; Weber-Ferguson; Lesões fibro-ósseas.ReferênciasFigueiredo LM, de Oliveira TF, Paraguassú GM, de Hollanda Valente RO, da Costa WR, Sarmento VA. Psammomatoid juvenile ossifying fibroma: case study and a review. Oral Maxillofac Surg. 2014;18(1):87-93.Speight PM, Takata T. New tumour entities in the 4th edition of the World Health Organization Classification of Head and Neck tumours: odontogenic and maxillofacial bone tumours. Virchows Arch. 2018;472(3):331-39.Linhares P, Pires E, Carvalho B, Vaz R. Juvenile psammomatoid ossifying fibroma of the orbit and paranasal sinuses. A case report. Acta Neurochir (Wien). 2011;153(10):1983-88.Figueiredo LMG, Valente ROH, Sarmento VA, Trindade SC, Oliveira TFL, Costa WRM. Aspectos atuais no diagnóstico e tratamento do fibroma ossificante juvenil. Rev bras cir cabeça pescoço. 2012;41(2):99-102.Agarwal SP, Kumar S, Singh HP, Usmani SA. Huge ossifying fibroma maxilla. Natl J Maxillofac Surg. 2015;6(2):241-43.Neville BW, Damm DD, Allen CM, Bouquot JE.  Patologia oral e maxilofacial. 3.ed. Rio de Janeiro: Elsevier;  2009.El-Mofty S. Psammomatoid and trabecular juvenile ossifying fibroma of the craniofacial skeleton: two distinct clinicopathologic entities. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;93(3):296-304.Nogueira RLM, Nonaka CFW, Cavalcante RB, Carvalho AC, Souza LB. Fibroma ossificante juvenil localizado em mandíbula: relato de caso e breve revisão da literatura. Rev cir traumatol buco-maxilo-fac. 2009; 9(1):25-32.Ranganath K, Kamath SM, Munoyath SK, Nandini HV. Juvenile psammomatoid ossifying fibroma of maxillary sinus: case report with review of literature. J Maxillofac Oral Surg. 2014;13(2):109-14.Toro C, Millesi W, Zerman N, Robiony M, Politi M. A case of aggressive ossifying fibroma with massive involvement in the mandible: differential diagnosis and management options. Int J Pediatr Otorhinolaryngol. 2006 Extra 1:167-72.Leimola-Virtanen R, Vähätalo K, Syrjänen S. Juvenile active ossifying fibroma of the mandible: a report of 2 cases. J Oral Maxillofac Surg. 2001;59(4):439-44.Papadaki ME, Troulis MJ, Kaban LB. Advances in diagnosis and management of fibro-osseous lesions. Oral Maxillofac Surg Clin North Am. 2005;17(4):415-34.Santos JN, Vieira TSLS, Góis Filho DM, Vasconcelos SJA, Azevedo RA. Displasia fibrosa: osteoplastia com acesso Weber-Ferguson. Relato de caso. Rev cir traumatol buco-maxilo-fac. 2010;10(1):73-80.Melo RB, Silva PF, Gonçalves FLN, Rodrigues AL, Pontes HAR. Tratamento cirúrgico de granuloma central de células gigantes agressivo em maxila com acesso Weber Ferguson: Relato de caso. Rev cir traumatol buco-maxilo-fac. 2014; 14(4):65-70.Reddy AV, Reddy KR, Prakash AR, Rajinikanth, Vidhyadhari P. Juvenile ossifying fibroma with aneurysamal bone cyst: a case report. J Clin Diagn Res. 2014;8(10):ZD01-ZD2.Slootweg PJ, Müller H. Juvenile ossifying fibroma. Report of four cases. J Craniomaxillofac Surg. 1990;18(3):125-29.Chiavaioli GMO. Fibroma ossificante juvenil em mandíbula: Relato de caso [monografia]. Belo Horizonte: Faculdade de Odontologia da Universidade Federal de Minas Gerais; 2015.

scholarly journals Recurrent juvenile psammomatoid ossifying fibroma with secondary aneurysmal bone cyst of the maxilla: a case report and review of literature

2018 ◽  
Author(s):  
Sachin C. Sarode ◽  
Gargi S. Sarode ◽  
Yashwant Ingale ◽  
Manjusha Ingale ◽  
Barnali Majumdar ◽  
...  
Keyword(s):  
Case Report ◽  
Aneurysmal Bone Cyst ◽  
English Literature ◽  
Bone Cyst ◽  
Growth Potential ◽  
Ossifying Fibroma ◽  
Surgical Removal ◽  
Juvenile Ossifying Fibroma ◽  
Secondary Aneurysmal Bone Cyst ◽  
Psammomatoid Ossifying Fibroma

Juvenile ossifying fibroma is a benign fibro-osseous lesion commonly affecting the extra-gnathic craniofacial skeleton of the young individuals. The psammomatoid and trabecular variants are its two histopathological subtypes having distinctive clinico-pathological characteristics. Secondary aneurysmal bone cysts are frequently reported to arise in the pre-existing fibro-osseous lesions but rarely reported in the psammmomatoid variant of the juvenile ossifying fibroma. Such hybrid lesions, especially massive in size, tend to exhibit a greater aggressive growth potential and higher recurrence rate and mandate complete surgical removal of the lesion along with a long-term follow-up. The objective of this case report was to present a rare incident of recurrent psammomatoid ossifying fibroma associated with a secondary aneurysmal bone cyst in the maxillary jaw bone of a young patient and review the similar published reports in the English literature.

scholarly journals Atypical Presentation of Giant Mandibular Aneurysmal Bone Cyst with Cemento-Ossifying Fibroma Mimicking Sarcoma

2019 ◽  
Vol 2019 ◽  
pp. 1-5
Author(s):  
Haneen Al-Maghrabi ◽  
Serge Verne ◽  
Bassam Al-Maghrabi ◽  
Osamah Almutawa ◽  
Jaudah Al-Maghrabi
Keyword(s):  
English Literature ◽  
Bone Cyst ◽  
World Health ◽  
Bone Lesions ◽  
Ossifying Fibroma ◽  
The Past ◽  
The World ◽  
Aneurysmal Bone Cysts ◽  
Bony Lesion ◽  
Health Organization

Aneurysmal bone cysts (ABCs) are an uncommon osteolytic intraosseous bone lesions. ABCs commonly involve metaphysis of long bones and are rarely diagnosed in craniofacial bones. The World Health Organization (WHO) designates ABCs as benign, but locally destructive, rapidly growing masses. ABC can be clinically misdiagnosed as a malignant tumor. In this article, we present a case of a 12-year-old female patient who presented to a maxillofascial outpatient clinic complaining of huge jaw swelling over the past 3 months, which was clinically suggestive of sarcoma. Few reported cases in the English literature describe ABC presented with huge rapidly growing mass causing destructive bony lesion that was clinically mimic sarcoma, which initiates this case report. We also discuss the most important pathologic differential diagnosis of tumors with malignant behavior and review the literature.

Preventing Premature Weaning: Management Options for Common Lactation Conditions, Including OMT

2020 ◽  
pp. 20-25
Author(s):  
Denise Sackett ◽  
Tala Dajani ◽  
David Shoup ◽  
Uzoma Ikonne
Keyword(s):  
Postpartum Depression ◽  
Family Physician ◽  
Treatment Options ◽  
World Health ◽  
Management Options ◽  
Pharmacological Management ◽  
Control And Prevention ◽  
Lactational Mastitis ◽  
One Year ◽  
Health Organization

The benefits of breastfeeding are well established. The World Health Organization and the Centers for Disease Control and Prevention recommend that mothers breastfeed infants for at least one year, but most children are not breastfed that long because of many factors. Breastfeeding mothers face many challenges to continued breastfeeding, including medical conditions that arise during this period, such as postpartum depression and lactational mastitis. Because of a perceived lack of consistent guidance on medication safety, it can be difficult for the family physician to treat these conditions while encouraging mothers to continue breastfeeding. The purpose of the current review is to summarize and clarify treatment options for the osteopathic family physician treating lactating mothers. We specifically focus on the pharmacological management of contraception, postpartum depression, and lactational mastitis.

Nonkeratinizing Nasopharyngeal Carcinoma, Undifferentiated Type With Trisomy 2: A Case Report and Short Review of Cytogenetic and Molecular Literature

2020 ◽  
Vol 23 (6) ◽  
pp. 448-452
Author(s):  
Francesco Pontoriero ◽  
Ayaka M Silverman ◽  
Judy M Pascasio ◽  
Renu Bajaj
Keyword(s):  
Case Report ◽  
Nasopharyngeal Carcinoma ◽  
Xenograft Model ◽  
Short Review ◽  
Undifferentiated Carcinoma ◽  
World Health ◽  
Surface Epithelium ◽  
Barr Virus ◽  
Cytogenetic Aberration ◽  
Health Organization

Carcinoma originating from the surface epithelium of the nasopharynx is classified by the World Health Organization (WHO) as nasopharyngeal carcinoma (NPC) and has 3 main types: keratinizing squamous cell carcinoma (WHO type 1) and nonkeratinizing carcinoma, differentiated (WHO type II), and undifferentiated (WHO type III). Nonkeratinizing NPC is strongly associated with prior Epstein–Barr virus (EBV) infection. These tumors may be divided into differentiated and undifferentiated carcinoma. Histologically, the tumor is characterized by syncytia of large malignant cells with vesicular nuclei, conspicuous nucleoli, and easily observed mitotic figures. We report a case of a 14-year-old boy diagnosed with EBV and human papillomavirus (HPV)-positive NPC (WHO type 3) with cytogenetics showing the presence of mosaic trisomy 2. This case report brings to light a rare cytogenetic aberration to our knowledge only reported once before in the literature in a xenograft model.

scholarly journals A Case of Polyneuropathy Following a Single Dose of Diethylcarbamazine and Albendazole During Mass Administration of Drug - A Case Report

1970 ◽  
Vol 1 (1) ◽  
pp. 56-58
Author(s):  
SC Kohli ◽  
UK Shrestha ◽  
VM Alurkar ◽  
A Maskey ◽  
M Parajuli ◽  
...  
Keyword(s):  
Abdominal Pain ◽  
Single Dose ◽  
Case Report ◽  
Side Effects ◽  
World Health Organization ◽  
Mass Drug Administration ◽  
World Health ◽  
Medical Sciences ◽  
The World ◽  
Health Organization

The global program to eliminate Lymphatic Filariasis created by The World Health organization in 1997 is based on mass administration of single annual doses of diethylcarbamazine ( DEC) plus albendazole in non African regions and of albendazole plus ivermectin in Africa. The usual side effects of DEC treatment include fever, chills, arthralgia, headaches, nausea, and vomiting. Albendazole is associated with relatively few side effects consisting of occasional nausea, vomiting, abdominal pain, headache, reversible alopecia, elevated aminotransferases and rarely leucopenia and rash. We report a case of polyneuropathy in a young individual following DEC and albendazole during mass drug administration. Keywords: Albendazole; DEC; Polyneuropathy. DOI: http://dx.doi.org/10.3126/njms.v1i1.5800   Nepal Journal of Medical Sciences. 2012; 1(1): 56-58

Sign in / Sign up

Export Citation Format

Share Document